Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...

We’ve long considered Apple’s iPads to be the best tablets on the market, but determining exactly which model you should buy isn’t always straightforward. Do you just want a big screen for streaming ...